Preventing Alcohol-Related Deaths Through Social Detoxification, 12956-12964 [2023-04151]
Download as PDF
12956
Federal Register / Vol. 88, No. 40 / Wednesday, March 1, 2023 / Notices
the Amendments to the International
Health Regulations (2005).
Matters to be Discussed: The listening
session will discuss potential
amendments to the IHR (2005). Topics
will include those amendments
currently under consideration by the
Working Group. An Article-by-Article
Compilation of Proposed Amendments
to the International Health Regulations
(2005) can be found here: https://
apps.who.int/gb/wgihr/pdf_files/wgihr1/
WGIHR_Compilation-en.pdf.
Participation is welcome from
stakeholder communities, including:
• Public health and advocacy groups
• State, local, and Tribal groups
• Private industry
• Minority health organizations
• Academic and scientific
organizations, etc.
RSVP: Persons seeking to attend or
speak at the listening session must
register by Wednesday, March 8, 2023.
Registrants must include their full
name and organization, if any, and
indicate whether they are registering as
a listen-only attendee or as a speaker
participant to OGA.RSVP1@hhs.gov.
Requests to participate as a speaker
must include:
1. The name of the person desiring to
participate;
2. The organization(s) that person
represents, if any;
3. Identification of the primary
amendment of interest.
Other Information: Written comments
should be emailed to OGA.RSVP1@
hhs.gov with the subject line ‘‘Written
Comment Re: Stakeholder Listening
Session 1 for the WGIHR’’ by Friday,
March 31, 2023.
We look forward to your comments on
proposed amendments to the
International Health Regulations (2005).
Dated: February 23, 2023.
Susan Kim,
Chief of Staff, Office of Global Affairs.
[FR Doc. 2023–04160 Filed 2–28–23; 8:45 am]
BILLING CODE 4150–38–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
ddrumheller on DSK120RN23PROD with NOTICES
Indian Health Service
Preventing Alcohol-Related Deaths
Through Social Detoxification
Announcement Type: New.
Funding Announcement Number:
HHS–2023–IHS–PARD–0001.
Assistance Listing (Catalog of Federal
Domestic Assistance or CFDA) Number:
93.654.
VerDate Sep<11>2014
18:10 Feb 28, 2023
Jkt 259001
Key Dates
Application Deadline Date: March 31,
2023.
Earliest Anticipated Start Date: April
17, 2023.
I. Funding Opportunity Description
Statutory Authority
The Indian Health Service (IHS),
Office of Clinical and Preventive
Services, Division of Behavioral Health
(DBH) is accepting applications for
cooperative agreements for the
Preventing Alcohol-Related Deaths
(PARD) through Detoxification. This
program is authorized under the Snyder
Act, 25 U.S.C. 13; Consolidated
Appropriations Act, 2023, Public Law
117–328, 136 Stat. 4459 (2022); and the
Transfer Act, 42 U.S.C. 2001(a). This
program is described in the Assistance
Listings located at https://sam.gov/
content/home (formerly known as the
CFDA) under 93.654.
Background
According to the Centers for Disease
Control and Prevention (CDC) mortality
data (Centers for Disease Control and
Prevention, National Center for Health
Statistics. National Vital Statistics
System, Mortality 1999–2020 on CDC
WONDER Online Database, released in
2021), alcohol related deaths among
American Indian and Alaska Native (AI/
AN) persons is a significant and
persistent tragic outcome in the US.
From 2016 to 2020, the crude rates for
alcohol-related deaths was 51.9 (per
100,000) for AI/AN persons, nearly five
times higher than non-AI/AN persons
(11.7 per 100,000). The geography of
these deaths is telling, as 48% were in
a cluster across Arizona and New
Mexico. Twenty of those counties have
death rates over the 51.9 national rate.
The highest rates were within McKinley
County, with a 147.7 crude death rate
for AI/AN persons—nearly 13 times
higher than the rate for non-AI/AN,
nationally. In the most recent PARD
grant program (2017–2022, https://
www.gpo.gov/fdsys/pkg/FR-2017-08-14/
pdf/2017-17102.pdf), the estimated
alcohol-related crude death rates in the
proximities of the previous project sites
(https://www.ihs.gov/sites/asap/themes/
responsive2017/display_objects/
documents/pardaward
sbystate2017.pdf), McKinley County,
New Mexico (Gallup City project) and
Oglala Lakota County, South Dakota
(formerly Shannon County), remain
notably high. With this opportunity, in
coordination with the PARD awardee,
IHS will address increasing the clinical
capacity of services offered between the
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
awardee and local continuum of
services.
Purpose
The purpose of this program is to
increase access to community-based
prevention strategies that provide social
detoxification, evaluation, stabilization,
fostering patient readiness for and entry
into treatment for alcohol use, and other
substance use disorders In alignment
with the IHS 2019–2023 Strategic Plan
Goal 1: To ensure that comprehensive,
culturally appropriate personal and
public health services are available and
accessible to AI/AN people, the PARD
project is designed to provide
communities the ability to reduce
alcohol-related mortality and encourage
clients to seek additional alcohol and/or
substance use disorder treatment after
discharge from a detoxification program.
IHS will use this funding to focus on
the provision of services in Tribal and
Urban Indian communities with the
highest burden of alcohol-related deaths
among AI/AN persons. IHS analyzed the
national rates of causes of deaths using
the CDC data (Centers for Disease
Control and Prevention, National Center
for Health Statistics. National Vital
Statistics System, Mortality 1999–2020
on CDC WONDER Online Database,
released in 2021), and determined that
McKinley County, New Mexico (with
the largest city of Gallup), continues to
have the highest burden of alcoholrelated deaths among AI/AN persons.
Additionally, the 2017 Senate
Appropriations Committee Report 114–
281 expressed the Committee’s
expectation that IHS address alcohol
and substance abuse through Federal,
State, local, and tribal partners, calling
for a sustainable model for life-saving
community services, with specific
attention on the capabilities of the
Na’Nizhoozhi Center in Gallup, New
Mexico.
A consensus among clinical and
subject matter experts understand
detoxification does not provide the full
spectrum of alcohol and/or substance
use disorder treatment but can serve as
a pathway to seeking treatment and as
a component in the continuum of
services for alcohol and substance use
disorders (Substance Abuse and Mental
Health Services Administration
(SAMHSA) Treatment Improvement
Protocol (TIP) 45 (https://
www.samhsa.gov/resource/ebp/tip-45detoxification-substance-abusetreatment).
Required Activities
The PARD program requires
applicants to review the Substance
Abuse and Mental Health Services
E:\FR\FM\01MRN1.SGM
01MRN1
ddrumheller on DSK120RN23PROD with NOTICES
Federal Register / Vol. 88, No. 40 / Wednesday, March 1, 2023 / Notices
Administration (SAMHSA) Treatment
Improvement Protocol (TIP) 45 (https://
www.samhsa.gov/resource/ebp/tip-45detoxification-substance-abusetreatment), which identifies the
principle for the basis of the TIP. The
PARD program must include the three
critical components—evaluation,
stabilization, and fostering patient
readiness for and entry into treatment.
The three critical components identified
in the SAMHSA TIP 45 will serve as the
program objectives that each applicant
will be required to meet. The three
objectives include:
1. To evaluate clients encountering
the detoxification program by the
following methods:
a. testing for the presence of
substances of use either through the
bloodstream, urine or saliva tests,
breathalyzers, and visually; and,
b. measuring the client’s coordination
and concentration; and,
c. screening for co-occurring mental
and physical conditions; and
d. may include a comprehensive
assessment of the client’s medical and
psychological conditions, social
situations, and historical traumas.
The evaluation serves as the basis for
the initial treatment plan once a client
has been withdrawn successfully.
2. To stabilize the clients while in
detoxification, which includes the
following methods:
a. The medical and psychosocial
processes of assisting the client through
acute intoxication and withdrawal to
the attainment of a medically stable,
fully supported, substance-free state.
This may be done with the assistance of
medications, though in some
approaches, no medication is used.
b. Familiarizing patients with their
role and what to expect in the
detoxification program.
c. The detoxification staff seek the
involvement of the client’s social
support systems (family, employers,
significant others, congregations, etc.—
with release of confidentiality).
d. Provide hot meals, showers,
hygiene kits, and other activities of
daily living that are necessary for
individuals in detoxification and
treatment services.
e. Ensure evidence-based
interventions, promising/best practices,
and culture-based practices are
incorporated into the detoxification
curriculum while individuals are
participating in services.
3. To foster the client’s readiness for
and entry into treatment for alcohol use
disorders, and when appropriate, other
substance use disorders:
a. Preparing the client for entry into
alcohol and/or substance use disorder
VerDate Sep<11>2014
18:10 Feb 28, 2023
Jkt 259001
treatment by stressing the importance of
following through with their complete
continuum of care, as a documented
treatment plan.
b. It is highly recommended to
encourage clients to continue alcohol
and/or substance use disorder treatment
prior to discharge from the
detoxification program, and record the
commitment that is indicated by the
client in their documented treatment
plan.
c. Provide recovery pathways for all
clients (recorded in their respective
documented treatment plans) by linking
them to further treatment for alcohol
and/or substance use disorders,
including the facilitation of contact with
treatment providers and programs after
detoxification.
d. Measure the overall treatment
process, including the progress and
results of referrals, by following
individuals who enter the detoxification
program and throughout their follow-on
uses of alcohol and/or substance use
disorder treatment/rehabilitation after
detoxification, and record the results in
their respective treatment plans.
The IHS encourages applicants to
develop and submit a work plan that
emphasizes cross-system collaboration,
the inclusion of family and social
support systems, community resources,
and culturally appropriate approaches.
Grantees will be required to:
(1) Review and implement the
guidance of the SAMHSA TIP 45,
Detoxification and Substance Abuse
Treatment.
(2) Provide semi-annual reports to the
IHS program officer on the number of
individuals served, number of
individuals referred to treatment
services, number of individuals who
access services more than once, and
number of individuals who access safe
housing options.
(3) Collect data that accounts for all
the interventions provided to each
patient in a format that measures
operationally defined methods, content,
and dose.
(4) The data collected must account
for the service transitions for each
patient (e.g., transfer to the emergency
room, transfer to detoxification) in the
local continuum of care.
(5) The data collected must account
for the outcomes for each patient (e.g.,
incarceration, inpatient treatment,
sobriety, moved out of service area,
missing, and death).
(6) The complete patient-level data,
de-identified, will be securely
transferred by the awardee to the IHS
DBH National Data Coordinator every
quarter, for independent and nationally
comparative analysis.
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
12957
(7) Participate in the development,
implementation, and evaluation of a
strategy that prevents alcohol related
death.
(8) Participate in the development,
implementation, and evaluation of a
sustainable model for clinical capacity.
(9) Provide annual reports on
successes and challenges.
(10) Host annual site visits for IHS
officials to discuss progress,
partnerships, clinical capacity,
challenges, and opportunities for
improvement.
(11) Provide meals, showers, hygiene
kits, and other activities of daily living
that are necessary for individuals in
detoxification and treatment services.
The meals should only be provided
while the patient is in the detoxification
program to ensure proper nutrition and
safety for the patient.
(12) Ensure coordination with cultural
services and traditional healers to
provide services while individuals are
participating in services.
(13) If applicable, provide
transportation to and from medical
appointments or for medical clearance
and ensure that medication management
is offered while individuals are
participating in services.
(14) Must use 100 percent of IHS
award funds for services provided to
AI/AN individuals.
II. Award Information
Funding Instrument—Cooperative
Agreement
Estimated Funds Available
The total amount of funding
identified for the first budget year,
starting in fiscal year (FY) 2023 is
approximately $2 million. The amount
of funding available for competing and
subsequent continuation awards issued
under this announcement is subject to
the availability of appropriations and
budgetary priorities of the Agency. The
IHS is under no obligation to make
awards that are selected for funding
under this announcement.
Anticipated Number of Awards
Approximately one award will be
issued under this program
announcement.
Period of Performance
The project period is for 5 years.
Cooperative Agreement
Cooperative agreements awarded by
the Department of Health and Human
Services (HHS) are administered under
the same policies as grants. However,
the funding agency, IHS, is anticipated
to have substantial programmatic
E:\FR\FM\01MRN1.SGM
01MRN1
12958
Federal Register / Vol. 88, No. 40 / Wednesday, March 1, 2023 / Notices
involvement in the project during the
entire period of performance. Below is
a detailed description of the level of
involvement required of the IHS.
Substantial Agency Involvement
Description for Cooperative Agreement
(1) Participate in community-level
meetings with key stakeholders who
will develop a strategy to combat the
issue of alcohol use disorders and
subsequent alcohol-related deaths.
(2) Participate in annual site visits for
technical assistance on increasing the
clinical capacity of services offered
between the awardee and IHS programs,
where available.
(3) Provide subject matter expertise on
policies, procedures, guidelines, and
other services provided by the grantee.
(4) Provide guidance to the awardee
involving strategy, data collection,
analysis, reporting, coordination of
activities, and evaluation.
(5) Provide medical services as
appropriate for individuals requiring a
higher level of care, or medical
clearance.
(6) Monitor the overall progress and
challenges of the awardee’s program and
their adherence to the terms and
conditions of the cooperative agreement.
III. Eligibility Information
1. Eligibility
ddrumheller on DSK120RN23PROD with NOTICES
To be eligible for this funding
opportunity an applicant will be a
public or private institution operated by
a state, local, Tribal, or private entity
that operates direct, on-site alcohol and/
or substance use disorder treatment
services, including social alcohol
detoxification services, to AI/AN
persons. For purposes of this
announcement, ‘‘institution’’ means an
entity that provides substance use
disorder treatment services including
detoxification. Applicants must be able
to start services on the first day of the
award. Applicants must serve AI/AN
persons.
The Division of Grants Management
(DGM) will notify any applicants
deemed ineligible.
Note: Please refer to Section IV.2
(Application and Submission Information/
Subsection 2, Content and Form of
Application Submission) for additional proof
of applicant status documents required, such
as Tribal Resolutions, proof of nonprofit
status, etc.
2. Cost Sharing or Matching
The IHS does not require matching
funds or cost sharing for grants or
cooperative agreements.
VerDate Sep<11>2014
18:10 Feb 28, 2023
Jkt 259001
3. Other Requirements
Applications with budget requests
that exceed the highest dollar amount
outlined under Section II Award
Information, Estimated Funds Available,
or exceed the period of performance
outlined under Section II Award
Information, Period of Performance, are
considered not responsive and will not
be reviewed. If deemed ineligible, IHS
will not return the application. The
applicant will be notified by email by
the Division of Grants Management
(DGM) of this decision.
Additional Required Documentation
Proof of Nonprofit Status
Organizations claiming nonprofit
status must submit a current copy of the
501(c)(3) Certificate with the
application, by the Application
Deadline Date listed under the Key
Dates section on page 1 of this
announcement.
An applicant submitting any of the
above additional documentation after
the initial application submission due
date is required to ensure the
information was received by the IHS
DGM by obtaining documentation
confirming delivery (i.e., FedEx
tracking, postal return receipt, etc.).
IV. Application and Submission
Information
Grants.gov uses a Workspace model
for accepting applications. The
Workspace consists of several online
forms and three forms in which to
upload documents—Project Narrative,
Budget Narrative, and Other Documents.
Give your files brief descriptive names.
The filenames are key in finding
specific documents during the objective
review and in processing awards.
Upload all requested and optional
documents individually, rather than
combining them into a single file.
Creating a single file creates confusion
when trying to find specific documents.
Such confusion can contribute to delays
in processing awards, and could lead to
lower scores during the objective
review.
1. Obtaining Application Materials
The application package and detailed
instructions for this announcement are
available at https://www.Grants.gov.
Please direct questions regarding the
application process to DGM@ihs.gov.
2. Content and Form Application
Submission
Mandatory documents for all
applicants include:
• Application forms:
1. SF–424, Application for Federal
Assistance.
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
2. SF–424A, Budget Information—
Non-Construction Programs.
3. SF–424B, Assurances—NonConstruction Programs.
4. Project Abstract Summary form.
• Project Narrative (not to exceed 10
pages). See Section IV.2.A, Project
Narrative for instructions.
• Budget Narrative (not to exceed 5
pages). See Section IV.2.B, Budget
Narrative for instructions.
• Letters of Support from
organization’s Board of Directors, Tribal
partners, and community stakeholders.
• 501(c)(3) Certificate (if applicable).
• Biographical sketches for all key
personnel.
• Contractor/Consultant resumes or
qualifications and scope of work.
• Disclosure of Lobbying Activities
(SF–LLL), if applicant conducts
reportable lobbying.
• Certification Regarding Lobbying
(GG-Lobbying Form).
• Copy of current Negotiated Indirect
Cost (IDC) rate agreement (required in
order to receive IDC).
• Organizational Chart (optional).
• Documentation of current Office of
Management and Budget (OMB)
Financial Audit (if applicable).
Acceptable forms of documentation
include:
1. Email confirmation from Federal
Audit Clearinghouse (FAC) that audits
were submitted; or
2. Face sheets from audit reports.
Applicants can find these on the FAC
website at https://facdissem.census.gov/.
Public Policy Requirements
All Federal public policies apply to
IHS grants and cooperative agreements.
Pursuant to 45 CFR 80.3(d), an
individual shall not be deemed
subjected to discrimination by reason of
their exclusion from benefits limited by
Federal law to individuals eligible for
benefits and services from the IHS. See
https://www.hhs.gov/grants/grants/
grants-policies-regulations/.
Requirements for Project and Budget
Narratives
A. Project Narrative: This narrative
must be a separate document that is no
more than 10 pages and must: (1) have
consecutively numbered pages; (2) use
black font 12 points or larger (applicants
may use 10 point font for tables); (3) be
single-spaced; and (4) be formatted to fit
standard letter paper (81⁄2 x 11 inches).
Do not combine this document with any
others.
Be sure to succinctly answer all
questions listed under the evaluation
criteria (refer to Section V.1, Evaluation
Criteria), and place all responses and
required information in the correct
E:\FR\FM\01MRN1.SGM
01MRN1
Federal Register / Vol. 88, No. 40 / Wednesday, March 1, 2023 / Notices
section noted below or they will not be
considered or scored. If the narrative
exceeds the overall page limit, reviewers
will be directed to ignore any content
beyond the page limit. The 10-page limit
for the project narrative does not
include the standard forms, budget,
budget narratives, and/or other items.
Page limits for each section within the
project narrative are guidelines, not
hard limits.
There are three parts to the project
narrative:
Part 1—Program Information;
Part 2—Program Planning and
Evaluation; and
Part 3—Program Report.
See below for additional details about
what must be included in the narrative.
The page limits below are for each
narrative and budget submitted.
Part 1: Program Information (Limit—2
Pages)
Section 1: Needs.
Describe the current issue of alcohol
use disorders, alcohol-related deaths,
and rates of alcohol-related liver
cirrhosis, as well as other social and
health issues impacted by alcoholrelated deaths. Describe the program’s
current social detoxification program,
who operates it, number of employees,
how long it has been operating, and
what programs or services are currently
being provided. Provide a statement of
fact on the clientele served, average
daily census, and ratio of individuals
served who are enrolled members of
federally recognized Tribes to those who
are not.
ddrumheller on DSK120RN23PROD with NOTICES
Part 2: Program Planning and Evaluation
(Limit—6 Pages)
Section 1: Program Plans.
Describe fully and clearly the
direction the applicant plans to take to
provide detoxification services,
including the three critical components:
evaluation, stabilization, and fostering
patient readiness for and entry into
treatment. Describe how the applicant
will provide safe housing and custodial
care in a safe environment by employees
who have successfully passed
background checks, who have been
trained in social detoxification, and who
are familiar with the features of
substance use withdrawal, have training
in basic life support, and have access to
emergency medical systems. Describe
how the applicant will provide
appropriate monitoring and security to
prevent self-harm of served individuals
and harm to others. Describe how the
applicant has the ability to provide
transportation to and from emergency
departments, as needed. Further
VerDate Sep<11>2014
18:10 Feb 28, 2023
Jkt 259001
information on general guidelines for
addressing these needs can be found in
the SAMHSA TIP–45.
Describe fully and clearly the types of
community partnerships and referral
providers to provide health and
behavioral health treatment services,
among others. Include information
about how the applicant will implement
a communication and support strategy
that includes family members of
individuals served (with their consent).
Describe the applicant’s ability to
provide daily activities of living such as
exercise, showers, meals, personal
hygiene, blankets, and appropriate
clothing. Include information on how
the applicant will provide culturally
appropriate interventions and activities.
Provide details on nurse support for
medical issues and medication
management and referral to a higher
level of care, when needed; medication
management, assessments, and
screening of clients; and case
management services.
Section 2: Program Evaluation.
This section of the project narrative
should describe your organization’s
plan for gathering client-specific nonidentifiable data, submitting data
requirements, and documenting the
ability to ensure accurate digital data
collection and reporting on community
and client level activities, including
those that correspond to treatment
plans. The applicant should describe
how their program intends to evaluate
its activities to include successes,
challenges, outputs, and outcomes.
Some examples of activities include
training of staff on observation and signs
to look for in clients encountering the
detoxification program; safety protocols;
organizational protocols and
procedures; safety plans; data collection
methods and support systems for
collecting data; partnerships developed
and sustained; and recovery support
activities provided for clients.
Part 3: Program Report (Limit—2 Pages)
Section 1: Describe your
organization’s significant program
activities and accomplishments as a
detoxification program over the past 5
years associated with the goals of this
announcement. Please identify current
staffing and key personnel who will be
responsible for the management of the
cooperative agreement.
Additionally, the applicant’s should
describe their ability to report on
collaboration and networking with local
partners. Reporting elements will
pertain to activities, processes, barriers,
and outcomes and include any partners
who will assist in evaluation efforts if
separate from the primary applicant.
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
12959
B. Budget Narrative (Limit—5 Pages)
Provide a budget narrative that
explains the amounts requested for each
line item of the budget from the SF–
424A (Budget Information for NonConstruction Programs) for the first year
of the project. The applicant can submit
with the budget narrative a more
detailed spreadsheet than is provided by
the SF–424A (the spreadsheet will not
be considered part of the budget
narrative). The budget narrative should
specifically describe how each item will
support the achievement of proposed
objectives. Be very careful about
showing how each item in the ‘‘Other’’
category is justified. Do NOT use the
budget narrative to expand the project
narrative.
3. Submission Dates and Times
Applications must be submitted
through Grants.gov by 11:59 p.m.
Eastern Time on the Application
Deadline Date. Any application received
after the application deadline will not
be accepted for review. Grants.gov will
notify the applicant via email if the
application is rejected.
If technical challenges arise and
assistance is required with the
application process, contact Grants.gov
Customer Support (see contact
information at https://www.Grants.gov).
If problems persist, contact Mr. Paul
Gettys, Deputy Director, DGM, by email
at DGM@ihs.gov. Please be sure to
contact Mr. Gettys at least 10 days prior
to the application deadline. Please do
not contact the DGM until you have
received a Grants.gov tracking number.
In the event you are not able to obtain
a tracking number, call the DGM as soon
as possible.
The IHS will not acknowledge receipt
of applications.
4. Intergovernmental Review
Executive Order 12372 requiring
intergovernmental review is not
applicable to this program.
5. Funding Restrictions
• Pre-award costs are allowable up to
90 days before the start date of the
award provided the costs are otherwise
allowable if awarded. Pre-award costs
are incurred at the risk of the applicant.
• The available funds are inclusive of
direct and indirect costs.
• Only one cooperative agreement
under this program may be awarded per
applicant.
6. Electronic Submission Requirements
All applications must be submitted
via Grants.gov. Please use the https://
www.Grants.gov website to submit an
application. Find the application by
E:\FR\FM\01MRN1.SGM
01MRN1
ddrumheller on DSK120RN23PROD with NOTICES
12960
Federal Register / Vol. 88, No. 40 / Wednesday, March 1, 2023 / Notices
selecting the ‘‘Search Grants’’ link on
the homepage. Follow the instructions
for submitting an application under the
Package tab. No other method of
application submission is acceptable.
If you cannot submit an application
through Grants.gov, you must request a
waiver prior to the application due date.
You must submit your waiver request by
email to DGM@ihs.gov, with a copy to
Mr. Paul Gettys, Deputy Director, DGM,
at Paul.Gettys@ihs.gov. Your waiver
request must include clear justification
for the need to deviate from the required
application submission process. The
IHS will not accept any applications
submitted through any means outside of
Grants.gov without an approved waiver.
If the DGM approves your waiver
request, you will receive a confirmation
of approval email containing
submission instructions. You must
include a copy of the written approval
with the application submitted to the
DGM. Late applications or application
that do not include a copy of the signed
waiver from the Deputy Director of the
DGM will not be reviewed. The Grants
Management Officer of the DGM will
notify the applicant via email of this
decision. Applications submitted under
waiver must be received by the DGM no
later than 5:00 p.m. Eastern Time on the
Application Deadline Date. Late
applications will not be accepted for
processing. Applicants that do not
register for both the System for Award
Management (SAM) and Grants.gov
and/or fail to request timely assistance
with technical issues will not be
considered for a waiver to submit an
application via alternative method.
Please be aware of the following:
• Please search for the application
package in https://www.Grants.gov by
entering the Assistance Listing (CFDA)
number or the Funding Opportunity
Number. Both numbers are located in
the header of this announcement.
• If you experience technical
challenges while submitting your
application, please contact Grants.gov
Customer Support (see contact
information at https://www.Grants.gov).
• Upon contacting Grants.gov, obtain
a tracking number as proof of contact.
The tracking number is helpful if there
are technical issues that cannot be
resolved and a waiver from the agency
must be obtained.
• Applicants are strongly encouraged
not to wait until the deadline date to
begin the application process through
Grants.gov as the registration process for
SAM and Grants.gov could take up to 20
working days.
• Please follow the instructions on
Grants.gov to include additional
VerDate Sep<11>2014
18:10 Feb 28, 2023
Jkt 259001
documentation that may be requested by
this funding announcement.
• Applicants must comply with any
page limits described in this funding
announcement.
• After submitting the application,
you will receive an automatic
acknowledgment from Grants.gov that
contains a Grants.gov tracking number.
The IHS will not notify you that the
application has been received.
System for Award Management (SAM)
Organizations that are not registered
with SAM must access the SAM online
registration through the SAM home page
at https://sam.gov. Organizations based
in the U.S. will also need to provide an
Employer Identification Number from
the Internal Revenue Service that may
take an additional 2–5 weeks to become
active. Please see SAM.gov for details on
the registration process and timeline.
Registration with the SAM is free of
charge but can take several weeks to
process. Applicants may register online
at https://sam.gov.
Unique Entity Identifier
Your SAM.gov registration now
includes a Unique Entity Identifier
(UEI), generated by SAM.gov, which
replaces the DUNS number obtained
from Dun and Bradstreet. SAM.gov
registration no longer requires a DUNS
number.
Check your organization’s SAM.gov
registration as soon as you decide to
apply for this program. If your SAM.gov
registration is expired, you will not be
able to submit an application. It can take
several weeks to renew it or resolve any
issues with your registration, so do not
wait.
Check your Grants.gov registration.
Registration and role assignments in
Grants.gov are self-serve functions. One
user for your organization will have the
authority to approve role assignments,
and these must be approved for active
users in order to ensure someone in
your organization has the necessary
access to submit an application.
The Federal Funding Accountability
and Transparency Act of 2006, as
amended (‘‘Transparency Act’’),
requires all HHS awardees to report
information on sub-awards.
Accordingly, all IHS awardees must
notify potential first-tier sub-awardees
that no entity may receive a first-tier
sub-award unless the entity has
provided its UEI number to the prime
awardee organization. This requirement
ensures the use of a universal identifier
to enhance the quality of information
available to the public pursuant to the
Transparency Act.
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
Additional information on
implementing the Transparency Act,
including the specific requirements for
SAM, are available on the DGM Grants
Management, Policy Topics web page at
https://www.ihs.gov/dgm/policytopics/.
V. Application Review Information
Possible points assigned to each
section are noted in parentheses. The
project narrative and budget narrative
should include only the first year of
activities. The project narrative should
be written in a manner that is clear to
outside reviewers unfamiliar with prior
related activities of the applicant. It
should be well organized, succinct, and
contain all information necessary for
reviewers to fully understand the
project. Attachments requested in the
criteria do not count toward the page
limit for the narratives. Points will be
assigned to each evaluation criteria
adding up to a total of 100 possible
points. Points are assigned as follows:
1. Evaluation Criteria
The purpose of this funding
opportunity is to support programs that
provide detoxification for alcohol use
disorders and when appropriate, other
substance use disorders to address its
impact in AI/AN populations and
reduce the mortality associated with
alcohol and other substance use. The
applicant must describe fully and
clearly the following areas.
A. Part 1: Program Information (40
Points)
1. The impact of alcohol use
disorders, alcohol-related deaths,
alcohol-related morbidity, and other
social and health issues attributed to
alcohol and other substances in the
community they serve.
2. The status of the social
detoxification program, who operates it,
the number of employees, how long it
has been in operation, and what
programs or services are being provided.
3. Demonstrate the need for funding
and how the funding will complement,
enhance, increase, and/or expand the
services currently provided.
4. The applicant’s service population,
clientele served, average daily census,
and ratio of individuals served who are
enrolled members of federally
recognized Tribes to those who are not.
5. The applicant’s readiness and
capacity to provide services on day one
of the award.
6. The applicant’s staffing level,
experience and education of staff, and
key personnel who will manage the
project.
E:\FR\FM\01MRN1.SGM
01MRN1
ddrumheller on DSK120RN23PROD with NOTICES
Federal Register / Vol. 88, No. 40 / Wednesday, March 1, 2023 / Notices
B. Part 2: Program Planning and
Evaluation (40 Points)
its activities to include successes,
challenges, outputs, and outcomes.
Section 1: Program Planning.
1. The applicant’s description of the
social detoxification program that
includes the three critical components
of evaluation, stabilization, and
fostering patient readiness for and entry
into treatment.
2. The applicant’s plans to provide
safe housing, including custodial care in
a safe environment.
3. The applicant’s process of ensuring
employees have passed background
checks and are trained in appropriate
alcohol and substance use disorder
identification; withdrawal management;
emergency and crisis intervention
training; evidence/culture-based
interventions and best practices; and
treatment approaches.
4. The applicant’s appropriate
monitoring of individuals accessing
services and security measures to ensure
safety and prevention of self-harm and
harm to others.
5. Community partnerships and
referral networks for health and
behavioral health treatment services,
including when medical intervention is
required for stabilization.
6. The applicant’s ability to provide
transportation to and from emergency
departments.
7. Communication strategies with the
client’s support system that fosters the
client’s recovery efforts upon consent
(i.e., family, social support groups, peer
recovery specialists, and traditional
healing services).
8. The applicant’s ability to provide
activities for daily living including
physical and mental exercises, showers,
meals, cultural activities, blankets,
appropriate clothing, and activities that
foster increased self-esteem, selfawareness, and self-efficacy.
9. The applicant’s ability to provide
clinical and behavioral health support
for medical issues and medication
management, assessments, screening,
referral to higher levels of care, and case
management.
Section 2: Program Evaluation.
10. The organization’s plan for
gathering client-specific nonidentifiable data.
11. The ability to ensure accurate
digital data collection and reporting on
community and client level activities.
12. The ability to report on
networking and partnering with local
partners through memorandums of
agreements/understanding, letters of
support, council/Tribal resolutions, and
coalition involvement.
13. The applicant should describe
how their program intends to evaluate
C. Part 3: Program Report (10 Points)
1. The applicant’s significant program
activities and accomplishments over the
past 5 years associated with the goals of
this funding opportunity.
2. Identifies current staffing and key
personnel who will be responsible for
the management of the cooperative
agreement.
3. The applicant’s ability to report on
collaboration and networking with local
partners and submit reporting elements
that pertain to activities, processes,
barriers, and outcomes.
4. Include any partners who will
assist in evaluation efforts if separate
from the primary applicant.
VerDate Sep<11>2014
18:10 Feb 28, 2023
Jkt 259001
D. Budget Narrative (10 Points)
1. How clearly the applicant
demonstrates each budget item aligns
with its proposal and program
approach.
2. The degree to which the applicant
budgets for evaluation activities.
Additional documents can be
uploaded as Other Attachments in
Grants.gov. These can include:
• Work plan, logic model, and/or
timeline for proposed objectives.
• Position descriptions for key staff.
• Resumes of key staff that reflect
current duties.
• Consultant or contractor proposed
scope of work and letter of commitment
(if applicable).
• Current Indirect Cost Rate
Agreement.
• Organizational chart.
• Map of area identifying project
location(s).
• Additional documents to support
narrative (i.e., data tables, key news
articles, etc.).
2. Review and Selection
Each application will be prescreened
for eligibility and completeness as
outlined in the funding announcement.
Applications that meet the eligibility
criteria shall be reviewed for merit by
the Objective Review Committee (ORC)
based on evaluation criteria. Incomplete
applications and applications that are
not responsive to the administrative
thresholds (budget limit, period of
performance limit) will not be referred
to the ORC and will not be funded. The
program office will notify the applicant
of this determination.
Applicants must address all program
requirements and provide all required
documentation.
3. Notifications of Disposition
All applicants will receive an
Executive Summary Statement from the
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
12961
IHS DBH within 30 days of the
conclusion of the ORC outlining the
strengths and weaknesses of their
application. The summary statement
will be sent to the Authorizing Official
identified on the face page (SF–424) of
the application.
A. Award Notices for Funded
Applications
The Notice of Award (NoA) is the
authorizing document for which funds
are dispersed to the approved entities
and reflects the amount of Federal funds
awarded, the purpose of the award, the
terms and conditions of the award, the
effective date of the award, and the
budget/project period. Each entity
approved for funding must have a user
account in GrantSolutions in order to
retrieve the NoA. Please see the Agency
Contacts list in Section VII for the
systems contact information.
B. Approved but Unfunded
Applications
Approved applications not funded
due to lack of available funds will be
held for 1 year. If funding becomes
available during the course of the year,
the application may be reconsidered.
Note: Any correspondence, other than the
official NoA executed by an IHS grants
management official announcing to the
project director that an award has been made
to their organization, is not an authorization
to implement their program on behalf of the
IHS.
VI. Award Administration Information
1. Administrative Requirements
Awards issued under this
announcement are subject to, and are
administered in accordance with, the
following regulations and policies:
A. The criteria as outlined in this
program announcement.
B. Administrative Regulations for
Grants:
• Uniform Administrative
Requirements, Cost Principles, and
Audit Requirements for HHS Awards
currently in effect or implemented
during the period of award, other
Department regulations and policies in
effect at the time of award, and
applicable statutory provisions. At the
time of publication, this includes 45
CFR part 75, at https://www.govinfo.gov/
content/pkg/CFR-2021-title45-vol1/pdf/
CFR-2021-title45-vol1-part75.pdf.
• Please review all HHS regulatory
provisions for Termination at 45 CFR
75.372, at the time of this publication
located at https://www.govinfo.gov/
content/pkg/CFR-2021-title45-vol1/pdf/
CFR-2021-title45-vol1-sec75-372.pdf.
C. Grants Policy:
E:\FR\FM\01MRN1.SGM
01MRN1
12962
Federal Register / Vol. 88, No. 40 / Wednesday, March 1, 2023 / Notices
ddrumheller on DSK120RN23PROD with NOTICES
• HHS Grants Policy Statement,
Revised January 2007, at https://
www.hhs.gov/sites/default/files/grants/
grants/policies-regulations/
hhsgps107.pdf.
D. Cost Principles:
• Uniform Administrative
Requirements for HHS Awards, ‘‘Cost
Principles,’’ at 45 CFR part 75, subpart
E, at the time of this publication located
at https://www.govinfo.gov/content/pkg/
CFR-2021-title45-vol1/pdf/CFR-2021title45-vol1-part75-subpartE.pdf.
E. Audit Requirements:
• Uniform Administrative
Requirements for HHS Awards, ‘‘Audit
Requirements,’’ at 45 CFR part 75,
subpart F, at the time of this publication
located at https://www.govinfo.gov/
content/pkg/CFR-2021-title45-vol1/pdf/
CFR-2021-title45-vol1-part75subpartF.pdf.
F. As of August 13, 2020, 2 CFR part
200 was updated to include a
prohibition on certain
telecommunications and video
surveillance services or equipment. This
prohibition is described in 2 CFR
200.216. This will also be described in
the terms and conditions of every IHS
grant and cooperative agreement
awarded on or after August 13, 2020. ‘‘If
you are successful and receive a Notice
of Award, in accepting the award, you
agree that the award and any activities
thereunder are subject to all provisions
of 45 CFR part 75, currently in effect or
implemented during the period of the
award, other Department regulations
and policies in effect at the time of the
award, and applicable statutory
provisions.’’
2. Indirect Costs
This section applies to all awardees
that request reimbursement of IDC in
their application budget. In accordance
with HHS Grants Policy Statement, Part
II–27, the IHS requires applicants to
obtain a current IDC rate agreement and
submit it to the DGM prior to the DGM
issuing an award. The rate agreement
must be prepared in accordance with
the applicable cost principles and
guidance as provided by the cognizant
agency or office. A current rate covers
the applicable grant activities under the
current award’s budget period. If the
current rate agreement is not on file
with the DGM at the time of award, the
IDC portion of the budget will be
restricted. The restrictions remain in
place until the current rate agreement is
provided to the DGM.
Per 45 CFR 75.414(f) Indirect (F&A)
costs,
any non-Federal entity (NFE) [i.e., applicant]
that has never received a negotiated indirect
cost rate, . . . may elect to charge a de
VerDate Sep<11>2014
18:10 Feb 28, 2023
Jkt 259001
minimis rate of 10 percent of modified total
direct costs which may be used indefinitely.
As described in Section 75.403, costs must be
consistently charged as either indirect or
direct costs, but may not be double charged
or inconsistently charged as both. If chosen,
this methodology once elected must be used
consistently for all Federal awards until such
time as the NFE chooses to negotiate for a
rate, which the NFE may apply to do at any
time.
Electing to charge a de minimis rate
of 10 percent only applies to applicants
that have never received an approved
negotiated indirect cost rate from HHS
or another cognizant Federal agency.
Applicants awaiting approval of their
indirect cost proposal may request the
10 percent de minimis rate. When the
applicant chooses this method, costs
included in the indirect cost pool must
not be charged as direct costs to the
grant.
Available funds are inclusive of direct
and appropriate indirect costs.
Approved indirect funds are awarded as
part of the award amount, and no
additional funds will be provided.
Generally, IDC rates for IHS awardees
are negotiated with the Division of Cost
Allocation at https://rates.psc.gov/ or
the Department of the Interior (Interior
Business Center) at https://ibc.doi.gov/
ICS/tribal. For questions regarding the
indirect cost policy, please call the
Grants Management Specialist listed
under ‘‘Agency Contacts’’ or write to
DGM@ihs.gov.
3. Reporting Requirements
The awardee must submit required
reports consistent with the applicable
deadlines. Failure to submit required
reports within the time allowed may
result in suspension or termination of
an active grant, withholding of
additional awards for the project, or
other enforcement actions such as
withholding of payments or converting
to the reimbursement method of
payment. Continued failure to submit
required reports may result in the
imposition of special award provisions
and/or the non-funding or non-award of
other eligible projects or activities. This
requirement applies whether the
delinquency is attributable to the failure
of the awardee organization or the
individual responsible for preparation
of the reports. Per DGM policy, all
reports must be submitted electronically
by attaching them as a ‘‘Grant Note’’ in
GrantSolutions. Personnel responsible
for submitting reports will be required
to obtain a login and password for
GrantSolutions. Please use the form
under the Recipient User section of
https://www.grantsolutions.gov/home/
getting-started-request-a-user-account/.
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
Download the Recipient User Account
Request Form, fill it out completely, and
submit it as described on the web page
and in the form.
The reporting requirements for this
program are noted below.
A. Progress Reports
Program progress reports are required
semi-annually. The progress reports are
due within 30 days after the reporting
period ends (specific dates will be listed
in the NoA Terms and Conditions).
These reports must include a brief
comparison of actual accomplishments
to the goals established for the period,
a summary of progress to date or, if
applicable, provide sound justification
for the lack of progress, and other
pertinent information as required. A
final report must be submitted within 90
days of expiration of the period of
performance.
B. Financial Reports
Federal Financial Reports are due 90
days after the end of each budget period,
and a final report is due 120 days after
the end of the period of performance.
Awardees are responsible and
accountable for reporting accurate
information on all required reports: the
Progress Reports and the Federal
Financial Report.
Failure to submit timely reports may
result in adverse award actions blocking
access to funds.
C. Data Collection and Reporting
All awardees will be required to
collect and report data pertaining to
activities, processes, and outcomes. The
IHS DBH will provide guidance on data
collection and reporting for evaluation
purposes within 6 months of award.
Programmatic reporting must be
submitted within 30 days after the
budget period ends for each project year
(specific dates will be listed in the NoA
Terms and Conditions). All reporting
items will be submitted via the Grant
Solutions. Technical assistance for webbased data entry will be timely and
readily available to awardees by
assigned IHS DBH staff. Awardees are
responsible and accountable for
accurate information being submitted by
required due dates for Data Collection
and Reporting.
D. Federal Sub-Award Reporting System
(FSRS)
This award may be subject to the
Transparency Act sub-award and
executive compensation reporting
requirements of 2 CFR part 170.
The Transparency Act requires the
OMB to establish a single searchable
database, accessible to the public, with
E:\FR\FM\01MRN1.SGM
01MRN1
Federal Register / Vol. 88, No. 40 / Wednesday, March 1, 2023 / Notices
ddrumheller on DSK120RN23PROD with NOTICES
information on financial assistance
awards made by Federal agencies. The
Transparency Act also includes a
requirement for awardees of Federal
grants to report information about firsttier sub-awards and executive
compensation under Federal assistance
awards.
The IHS has implemented a Term of
Award into all IHS Standard Terms and
Conditions, NoAs, and funding
announcements regarding the FSRS
reporting requirement. This IHS Term of
Award is applicable to all IHS grant and
cooperative agreements issued on or
after October 1, 2010, with a $25,000
sub-award obligation threshold met for
any specific reporting period.
For the full IHS award term
implementing this requirement and
additional award applicability
information, visit the DGM Grants
Management website at https://
www.ihs.gov/dgm/policytopics/.
E. Non-Discrimination Legal
Requirements for Awardees of Federal
Financial Assistance
The awardee must administer the
project in compliance with Federal civil
rights laws that prohibit discrimination
on the basis of race, color, national
origin, disability, age, and comply with
applicable conscience protections. The
awardee must comply with applicable
laws that prohibit discrimination on the
basis of sex, which includes
discrimination on the basis of gender
identity, sexual orientation, and
pregnancy. Compliance with these laws
requires taking reasonable steps to
provide meaningful access to persons
with limited English proficiency and
providing programs that are accessible
to and usable by persons with
disabilities. The HHS Office for Civil
Rights provides guidance on complying
with civil rights laws enforced by HHS.
See https://www.hhs.gov/civil-rights/forproviders/provider-obligations/
index.html and https://www.hhs.gov/
civil-rights/for-individuals/
nondiscrimination/.
• Recipients of FFA must ensure that
their programs are accessible to persons
with limited English proficiency. For
guidance on meeting your legal
obligation to take reasonable steps to
ensure meaningful access to your
programs or activities by limited English
proficiency individuals, see https://
www.hhs.gov/civil-rights/forindividuals/special-topics/limitedenglish-proficiency/fact-sheet-guidance/
index.html and https://www.lep.gov.
• For information on your specific
legal obligations for serving qualified
individuals with disabilities, including
reasonable modifications and making
VerDate Sep<11>2014
18:10 Feb 28, 2023
Jkt 259001
services accessible to them, see https://
www.hhs.gov/civil-rights/forindividuals/disability/.
• HHS funded health and education
programs must be administered in an
environment free of sexual harassment.
See https://www.hhs.gov/civil-rights/forindividuals/sex-discrimination/
index.html.
• For guidance on administering your
program in compliance with applicable
Federal religious nondiscrimination
laws and applicable Federal conscience
protection and associated antidiscrimination laws, see https://
www.hhs.gov/conscience/conscienceprotections/ and https://
www.hhs.gov/conscience/religiousfreedom/.
F. Federal Awardee Performance and
Integrity Information System (FAPIIS)
The IHS is required to review and
consider any information about the
applicant that is in the FAPIIS at
https://www.fapiis.gov/fapiis/#/home
before making any award in excess of
the simplified acquisition threshold
(currently $250,000) over the period of
performance. An applicant may review
and comment on any information about
itself that a Federal awarding agency
previously entered. The IHS will
consider any comments by the
applicant, in addition to other
information in FAPIIS, in making a
judgment about the applicant’s integrity,
business ethics, and record of
performance under Federal awards
when completing the review of risk
posed by applicants, as described in 45
CFR 75.205.
As required by 45 CFR part 75,
appendix XII of the Uniform Guidance,
NFEs are required to disclose in FAPIIS
any information about criminal, civil,
and administrative proceedings, and/or
affirm that there is no new information
to provide. This applies to NFEs that
receive Federal awards (currently active
grants, cooperative agreements, and
procurement contracts) greater than $10
million for any period of time during
the period of performance of an award/
project.
Mandatory Disclosure Requirements
As required by 2 CFR part 200 of the
Uniform Guidance, and the HHS
implementing regulations at 45 CFR part
75, the IHS must require an NFE or an
applicant for a Federal award to
disclose, in a timely manner, in writing
to the IHS or pass-through entity all
violations of Federal criminal law
involving fraud, bribery, or gratuity
violations potentially affecting the
Federal award.
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
12963
All applicants and awardees must
disclose in writing, in a timely manner,
to the IHS and to the HHS Office of
Inspector General all information
related to violations of Federal criminal
law involving fraud, bribery, or gratuity
violations potentially affecting the
Federal award. 45 CFR 75.113.
Disclosures must be sent in writing to:
U.S. Department of Health and Human
Services, Indian Health Service,
Division of Grants Management, ATTN:
Marsha Brookins, Director, 5600 Fishers
Lane, Mail Stop: 09E47, Rockville, MD
20857. (Include ‘‘Mandatory Grant
Disclosures’’ in subject line). Office:
(301) 443–4750. Fax: (301) 594–0899.
Email: DGM@ihs.gov.
AND
U.S. Department of Health and
Human Services, Office of Inspector
General, ATTN: Mandatory Grant
Disclosures, Intake Coordinator, 330
Independence Avenue SW, Cohen
Building, Room 5527, Washington, DC
20201. URL: https://oig.hhs.gov/fraud/
report-fraud/. (Include ‘‘Mandatory
Grant Disclosures’’ in subject line). Fax:
(202) 205–0604 (Include ‘‘Mandatory
Grant Disclosures’’ in subject line) or
Email: MandatoryGranteeDisclosures@
oig.hhs.gov.
Failure to make required disclosures
can result in any of the remedies
described in 45 CFR 75.371 Remedies
for noncompliance, including
suspension or debarment (see 2 CFR
part 180 and 2 CFR part 376).
VII. Agency Contacts
1. Questions on the programmatic
issues may be directed to: JB
Kinlacheeny, Public Health Advisor,
Indian Health Service, Division of
Behavioral Health, 5600 Fishers Lane,
Mail Stop: 0834NB, Rockville, MD
20857. Phone: (301) 443–0104. Email:
JB.Kinlacheeny@ihs.gov.
2. Questions on grants management
and fiscal matters may be directed to:
Indian Health Service, Division of
Grants Management, 5600 Fishers Lane,
Mail Stop: 09E47, Rockville, MD 20857,
Email: DGM@ihs.gov. For technical
assistance with Grants.gov, please
contact the Grants.gov help desk at 800–
518–4726, or by email at support@
grants.gov.
VIII. Other Information
The Public Health Service strongly
encourages all grant, cooperative
agreement, and contract awardees to
provide a smoke-free workplace and
promote the non-use of all tobacco
products. In addition, Public Law 103–
227, the Pro-Children Act of 1994,
prohibits smoking in certain facilities
E:\FR\FM\01MRN1.SGM
01MRN1
12964
Federal Register / Vol. 88, No. 40 / Wednesday, March 1, 2023 / Notices
(or in some cases, any portion of the
facility) in which regular or routine
education, library, day care, health care,
or early childhood development
services are provided to children. This
is consistent with the HHS mission to
protect and advance the physical and
mental health of the American people.
Roselyn Tso,
Director, Indian Health Service.
[FR Doc. 2023–04151 Filed 2–28–23; 8:45 am]
BILLING CODE 4165–16–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
ddrumheller on DSK120RN23PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Glioma, Multiple Sclerosis, and
Neuroinflammation.
Date: March 22, 2023.
Time: 10:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Samuel C. Edwards, Ph.D.,
Chief, BDCN IRG, Center for Scientific
Review, National Institutes of Health, 6701
Rockledge Drive, Room 5210, MSC 7846,
Bethesda, MD 20892, (301) 435–1246,
edwardss@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Neurodegeneration, Addiction, Eye,
and System Neuroscience.
Date: March 30, 2023.
Time: 9:00 a.m. to 12:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Pablo Miguel Blazquez
Gamez, Ph.D., Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
VerDate Sep<11>2014
18:10 Feb 28, 2023
Jkt 259001
Bethesda, MD 20892, (301) 435–1042,
pablo.blazquezgamez@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Cancer Biology.
Date: March 30, 2023.
Time: 10:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Charles Morrow, MD,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6202,
MSC 7804, Bethesda, MD 20892, 301–408–
9850, morrowcs@csr.nih.gov.
Name of Committee: Infectious Diseases
and Immunology B Integrated Review Group;
HIV Coinfections and HIV Associated
Cancers Study Section.
Date: March 30–31, 2023.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Joshua David Powell,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 594–5370, josh.powell@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Immunology and Infectious
Diseases C.
Date: March 30–31, 2023.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Shannon J. Sherman,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 594–0715, shannon.sherman@
nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Cell Structure, Function, and
Signaling.
Date: March 30, 2023.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Robert O’Hagan, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (240) 909–6378, ohaganr2@
csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Program
Projects: Drug Development.
Date: March 30, 2023.
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Kenneth Ryan, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3218,
MSC 7717, Bethesda, MD 20892, 301–435–
0229, kenneth.ryan@nih.hhs.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA:
Counter ACT Therapeutics Discovery and
Early-Stage Development and Basic Research
on Chemical Threats that Affect the Nervous
System.
Date: March 31, 2023.
Time: 8:30 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jodie Michelle Fleming,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 812R,
Bethesda, MD 20892, (301) 867–5309,
flemingjm@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: February 23, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–04140 Filed 2–28–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; Review of Research on Interventions
that Promote the Careers of Individuals in the
Biomedical Research Enterprise (R01).
E:\FR\FM\01MRN1.SGM
01MRN1
Agencies
[Federal Register Volume 88, Number 40 (Wednesday, March 1, 2023)]
[Notices]
[Pages 12956-12964]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-04151]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Indian Health Service
Preventing Alcohol-Related Deaths Through Social Detoxification
Announcement Type: New.
Funding Announcement Number: HHS-2023-IHS-PARD-0001.
Assistance Listing (Catalog of Federal Domestic Assistance or CFDA)
Number: 93.654.
Key Dates
Application Deadline Date: March 31, 2023.
Earliest Anticipated Start Date: April 17, 2023.
I. Funding Opportunity Description
Statutory Authority
The Indian Health Service (IHS), Office of Clinical and Preventive
Services, Division of Behavioral Health (DBH) is accepting applications
for cooperative agreements for the Preventing Alcohol-Related Deaths
(PARD) through Detoxification. This program is authorized under the
Snyder Act, 25 U.S.C. 13; Consolidated Appropriations Act, 2023, Public
Law 117-328, 136 Stat. 4459 (2022); and the Transfer Act, 42 U.S.C.
2001(a). This program is described in the Assistance Listings located
at https://sam.gov/content/home (formerly known as the CFDA) under
93.654.
Background
According to the Centers for Disease Control and Prevention (CDC)
mortality data (Centers for Disease Control and Prevention, National
Center for Health Statistics. National Vital Statistics System,
Mortality 1999-2020 on CDC WONDER Online Database, released in 2021),
alcohol related deaths among American Indian and Alaska Native (AI/AN)
persons is a significant and persistent tragic outcome in the US. From
2016 to 2020, the crude rates for alcohol-related deaths was 51.9 (per
100,000) for AI/AN persons, nearly five times higher than non-AI/AN
persons (11.7 per 100,000). The geography of these deaths is telling,
as 48% were in a cluster across Arizona and New Mexico. Twenty of those
counties have death rates over the 51.9 national rate. The highest
rates were within McKinley County, with a 147.7 crude death rate for
AI/AN persons--nearly 13 times higher than the rate for non-AI/AN,
nationally. In the most recent PARD grant program (2017-2022, https://www.gpo.gov/fdsys/pkg/FR-2017-08-14/pdf/2017-17102.pdf), the estimated
alcohol-related crude death rates in the proximities of the previous
project sites (https://www.ihs.gov/sites/asap/themes/responsive2017/display_objects/documents/pardawardsbystate2017.pdf), McKinley County,
New Mexico (Gallup City project) and Oglala Lakota County, South Dakota
(formerly Shannon County), remain notably high. With this opportunity,
in coordination with the PARD awardee, IHS will address increasing the
clinical capacity of services offered between the awardee and local
continuum of services.
Purpose
The purpose of this program is to increase access to community-
based prevention strategies that provide social detoxification,
evaluation, stabilization, fostering patient readiness for and entry
into treatment for alcohol use, and other substance use disorders In
alignment with the IHS 2019-2023 Strategic Plan Goal 1: To ensure that
comprehensive, culturally appropriate personal and public health
services are available and accessible to AI/AN people, the PARD project
is designed to provide communities the ability to reduce alcohol-
related mortality and encourage clients to seek additional alcohol and/
or substance use disorder treatment after discharge from a
detoxification program.
IHS will use this funding to focus on the provision of services in
Tribal and Urban Indian communities with the highest burden of alcohol-
related deaths among AI/AN persons. IHS analyzed the national rates of
causes of deaths using the CDC data (Centers for Disease Control and
Prevention, National Center for Health Statistics. National Vital
Statistics System, Mortality 1999-2020 on CDC WONDER Online Database,
released in 2021), and determined that McKinley County, New Mexico
(with the largest city of Gallup), continues to have the highest burden
of alcohol-related deaths among AI/AN persons. Additionally, the 2017
Senate Appropriations Committee Report 114-281 expressed the
Committee's expectation that IHS address alcohol and substance abuse
through Federal, State, local, and tribal partners, calling for a
sustainable model for life-saving community services, with specific
attention on the capabilities of the Na'Nizhoozhi Center in Gallup, New
Mexico.
A consensus among clinical and subject matter experts understand
detoxification does not provide the full spectrum of alcohol and/or
substance use disorder treatment but can serve as a pathway to seeking
treatment and as a component in the continuum of services for alcohol
and substance use disorders (Substance Abuse and Mental Health Services
Administration (SAMHSA) Treatment Improvement Protocol (TIP) 45
(https://www.samhsa.gov/resource/ebp/tip-45-detoxification-substance-abuse-treatment).
Required Activities
The PARD program requires applicants to review the Substance Abuse
and Mental Health Services
[[Page 12957]]
Administration (SAMHSA) Treatment Improvement Protocol (TIP) 45
(https://www.samhsa.gov/resource/ebp/tip-45-detoxification-substance-abuse-treatment), which identifies the principle for the basis of the
TIP. The PARD program must include the three critical components--
evaluation, stabilization, and fostering patient readiness for and
entry into treatment. The three critical components identified in the
SAMHSA TIP 45 will serve as the program objectives that each applicant
will be required to meet. The three objectives include:
1. To evaluate clients encountering the detoxification program by
the following methods:
a. testing for the presence of substances of use either through the
bloodstream, urine or saliva tests, breathalyzers, and visually; and,
b. measuring the client's coordination and concentration; and,
c. screening for co-occurring mental and physical conditions; and
d. may include a comprehensive assessment of the client's medical
and psychological conditions, social situations, and historical
traumas.
The evaluation serves as the basis for the initial treatment plan
once a client has been withdrawn successfully.
2. To stabilize the clients while in detoxification, which includes
the following methods:
a. The medical and psychosocial processes of assisting the client
through acute intoxication and withdrawal to the attainment of a
medically stable, fully supported, substance-free state. This may be
done with the assistance of medications, though in some approaches, no
medication is used.
b. Familiarizing patients with their role and what to expect in the
detoxification program.
c. The detoxification staff seek the involvement of the client's
social support systems (family, employers, significant others,
congregations, etc.-- with release of confidentiality).
d. Provide hot meals, showers, hygiene kits, and other activities
of daily living that are necessary for individuals in detoxification
and treatment services.
e. Ensure evidence-based interventions, promising/best practices,
and culture-based practices are incorporated into the detoxification
curriculum while individuals are participating in services.
3. To foster the client's readiness for and entry into treatment
for alcohol use disorders, and when appropriate, other substance use
disorders:
a. Preparing the client for entry into alcohol and/or substance use
disorder treatment by stressing the importance of following through
with their complete continuum of care, as a documented treatment plan.
b. It is highly recommended to encourage clients to continue
alcohol and/or substance use disorder treatment prior to discharge from
the detoxification program, and record the commitment that is indicated
by the client in their documented treatment plan.
c. Provide recovery pathways for all clients (recorded in their
respective documented treatment plans) by linking them to further
treatment for alcohol and/or substance use disorders, including the
facilitation of contact with treatment providers and programs after
detoxification.
d. Measure the overall treatment process, including the progress
and results of referrals, by following individuals who enter the
detoxification program and throughout their follow-on uses of alcohol
and/or substance use disorder treatment/rehabilitation after
detoxification, and record the results in their respective treatment
plans.
The IHS encourages applicants to develop and submit a work plan
that emphasizes cross-system collaboration, the inclusion of family and
social support systems, community resources, and culturally appropriate
approaches.
Grantees will be required to:
(1) Review and implement the guidance of the SAMHSA TIP 45,
Detoxification and Substance Abuse Treatment.
(2) Provide semi-annual reports to the IHS program officer on the
number of individuals served, number of individuals referred to
treatment services, number of individuals who access services more than
once, and number of individuals who access safe housing options.
(3) Collect data that accounts for all the interventions provided
to each patient in a format that measures operationally defined
methods, content, and dose.
(4) The data collected must account for the service transitions for
each patient (e.g., transfer to the emergency room, transfer to
detoxification) in the local continuum of care.
(5) The data collected must account for the outcomes for each
patient (e.g., incarceration, inpatient treatment, sobriety, moved out
of service area, missing, and death).
(6) The complete patient-level data, de-identified, will be
securely transferred by the awardee to the IHS DBH National Data
Coordinator every quarter, for independent and nationally comparative
analysis.
(7) Participate in the development, implementation, and evaluation
of a strategy that prevents alcohol related death.
(8) Participate in the development, implementation, and evaluation
of a sustainable model for clinical capacity.
(9) Provide annual reports on successes and challenges.
(10) Host annual site visits for IHS officials to discuss progress,
partnerships, clinical capacity, challenges, and opportunities for
improvement.
(11) Provide meals, showers, hygiene kits, and other activities of
daily living that are necessary for individuals in detoxification and
treatment services. The meals should only be provided while the patient
is in the detoxification program to ensure proper nutrition and safety
for the patient.
(12) Ensure coordination with cultural services and traditional
healers to provide services while individuals are participating in
services.
(13) If applicable, provide transportation to and from medical
appointments or for medical clearance and ensure that medication
management is offered while individuals are participating in services.
(14) Must use 100 percent of IHS award funds for services provided
to AI/AN individuals.
II. Award Information
Funding Instrument--Cooperative Agreement
Estimated Funds Available
The total amount of funding identified for the first budget year,
starting in fiscal year (FY) 2023 is approximately $2 million. The
amount of funding available for competing and subsequent continuation
awards issued under this announcement is subject to the availability of
appropriations and budgetary priorities of the Agency. The IHS is under
no obligation to make awards that are selected for funding under this
announcement.
Anticipated Number of Awards
Approximately one award will be issued under this program
announcement.
Period of Performance
The project period is for 5 years.
Cooperative Agreement
Cooperative agreements awarded by the Department of Health and
Human Services (HHS) are administered under the same policies as
grants. However, the funding agency, IHS, is anticipated to have
substantial programmatic
[[Page 12958]]
involvement in the project during the entire period of performance.
Below is a detailed description of the level of involvement required of
the IHS.
Substantial Agency Involvement Description for Cooperative Agreement
(1) Participate in community-level meetings with key stakeholders
who will develop a strategy to combat the issue of alcohol use
disorders and subsequent alcohol-related deaths.
(2) Participate in annual site visits for technical assistance on
increasing the clinical capacity of services offered between the
awardee and IHS programs, where available.
(3) Provide subject matter expertise on policies, procedures,
guidelines, and other services provided by the grantee.
(4) Provide guidance to the awardee involving strategy, data
collection, analysis, reporting, coordination of activities, and
evaluation.
(5) Provide medical services as appropriate for individuals
requiring a higher level of care, or medical clearance.
(6) Monitor the overall progress and challenges of the awardee's
program and their adherence to the terms and conditions of the
cooperative agreement.
III. Eligibility Information
1. Eligibility
To be eligible for this funding opportunity an applicant will be a
public or private institution operated by a state, local, Tribal, or
private entity that operates direct, on-site alcohol and/or substance
use disorder treatment services, including social alcohol
detoxification services, to AI/AN persons. For purposes of this
announcement, ``institution'' means an entity that provides substance
use disorder treatment services including detoxification. Applicants
must be able to start services on the first day of the award.
Applicants must serve AI/AN persons.
The Division of Grants Management (DGM) will notify any applicants
deemed ineligible.
Note: Please refer to Section IV.2 (Application and Submission
Information/Subsection 2, Content and Form of Application
Submission) for additional proof of applicant status documents
required, such as Tribal Resolutions, proof of nonprofit status,
etc.
2. Cost Sharing or Matching
The IHS does not require matching funds or cost sharing for grants
or cooperative agreements.
3. Other Requirements
Applications with budget requests that exceed the highest dollar
amount outlined under Section II Award Information, Estimated Funds
Available, or exceed the period of performance outlined under Section
II Award Information, Period of Performance, are considered not
responsive and will not be reviewed. If deemed ineligible, IHS will not
return the application. The applicant will be notified by email by the
Division of Grants Management (DGM) of this decision.
Additional Required Documentation
Proof of Nonprofit Status
Organizations claiming nonprofit status must submit a current copy
of the 501(c)(3) Certificate with the application, by the Application
Deadline Date listed under the Key Dates section on page 1 of this
announcement.
An applicant submitting any of the above additional documentation
after the initial application submission due date is required to ensure
the information was received by the IHS DGM by obtaining documentation
confirming delivery (i.e., FedEx tracking, postal return receipt,
etc.).
IV. Application and Submission Information
Grants.gov uses a Workspace model for accepting applications. The
Workspace consists of several online forms and three forms in which to
upload documents--Project Narrative, Budget Narrative, and Other
Documents. Give your files brief descriptive names. The filenames are
key in finding specific documents during the objective review and in
processing awards. Upload all requested and optional documents
individually, rather than combining them into a single file. Creating a
single file creates confusion when trying to find specific documents.
Such confusion can contribute to delays in processing awards, and could
lead to lower scores during the objective review.
1. Obtaining Application Materials
The application package and detailed instructions for this
announcement are available at https://www.Grants.gov.
Please direct questions regarding the application process to
[email protected].
2. Content and Form Application Submission
Mandatory documents for all applicants include:
Application forms:
1. SF-424, Application for Federal Assistance.
2. SF-424A, Budget Information--Non-Construction Programs.
3. SF-424B, Assurances--Non-Construction Programs.
4. Project Abstract Summary form.
Project Narrative (not to exceed 10 pages). See Section
IV.2.A, Project Narrative for instructions.
Budget Narrative (not to exceed 5 pages). See Section
IV.2.B, Budget Narrative for instructions.
Letters of Support from organization's Board of Directors,
Tribal partners, and community stakeholders.
501(c)(3) Certificate (if applicable).
Biographical sketches for all key personnel.
Contractor/Consultant resumes or qualifications and scope
of work.
Disclosure of Lobbying Activities (SF-LLL), if applicant
conducts reportable lobbying.
Certification Regarding Lobbying (GG-Lobbying Form).
Copy of current Negotiated Indirect Cost (IDC) rate
agreement (required in order to receive IDC).
Organizational Chart (optional).
Documentation of current Office of Management and Budget
(OMB) Financial Audit (if applicable).
Acceptable forms of documentation include:
1. Email confirmation from Federal Audit Clearinghouse (FAC) that
audits were submitted; or
2. Face sheets from audit reports. Applicants can find these on the
FAC website at https://facdissem.census.gov/.
Public Policy Requirements
All Federal public policies apply to IHS grants and cooperative
agreements. Pursuant to 45 CFR 80.3(d), an individual shall not be
deemed subjected to discrimination by reason of their exclusion from
benefits limited by Federal law to individuals eligible for benefits
and services from the IHS. See https://www.hhs.gov/grants/grants/grants-policies-regulations/.
Requirements for Project and Budget Narratives
A. Project Narrative: This narrative must be a separate document
that is no more than 10 pages and must: (1) have consecutively numbered
pages; (2) use black font 12 points or larger (applicants may use 10
point font for tables); (3) be single-spaced; and (4) be formatted to
fit standard letter paper (8\1/2\ x 11 inches). Do not combine this
document with any others.
Be sure to succinctly answer all questions listed under the
evaluation criteria (refer to Section V.1, Evaluation Criteria), and
place all responses and required information in the correct
[[Page 12959]]
section noted below or they will not be considered or scored. If the
narrative exceeds the overall page limit, reviewers will be directed to
ignore any content beyond the page limit. The 10-page limit for the
project narrative does not include the standard forms, budget, budget
narratives, and/or other items. Page limits for each section within the
project narrative are guidelines, not hard limits.
There are three parts to the project narrative:
Part 1--Program Information;
Part 2--Program Planning and Evaluation; and
Part 3--Program Report.
See below for additional details about what must be included in the
narrative.
The page limits below are for each narrative and budget submitted.
Part 1: Program Information (Limit--2 Pages)
Section 1: Needs.
Describe the current issue of alcohol use disorders, alcohol-
related deaths, and rates of alcohol-related liver cirrhosis, as well
as other social and health issues impacted by alcohol-related deaths.
Describe the program's current social detoxification program, who
operates it, number of employees, how long it has been operating, and
what programs or services are currently being provided. Provide a
statement of fact on the clientele served, average daily census, and
ratio of individuals served who are enrolled members of federally
recognized Tribes to those who are not.
Part 2: Program Planning and Evaluation (Limit--6 Pages)
Section 1: Program Plans.
Describe fully and clearly the direction the applicant plans to
take to provide detoxification services, including the three critical
components: evaluation, stabilization, and fostering patient readiness
for and entry into treatment. Describe how the applicant will provide
safe housing and custodial care in a safe environment by employees who
have successfully passed background checks, who have been trained in
social detoxification, and who are familiar with the features of
substance use withdrawal, have training in basic life support, and have
access to emergency medical systems. Describe how the applicant will
provide appropriate monitoring and security to prevent self-harm of
served individuals and harm to others. Describe how the applicant has
the ability to provide transportation to and from emergency
departments, as needed. Further information on general guidelines for
addressing these needs can be found in the SAMHSA TIP-45.
Describe fully and clearly the types of community partnerships and
referral providers to provide health and behavioral health treatment
services, among others. Include information about how the applicant
will implement a communication and support strategy that includes
family members of individuals served (with their consent). Describe the
applicant's ability to provide daily activities of living such as
exercise, showers, meals, personal hygiene, blankets, and appropriate
clothing. Include information on how the applicant will provide
culturally appropriate interventions and activities. Provide details on
nurse support for medical issues and medication management and referral
to a higher level of care, when needed; medication management,
assessments, and screening of clients; and case management services.
Section 2: Program Evaluation.
This section of the project narrative should describe your
organization's plan for gathering client-specific non-identifiable
data, submitting data requirements, and documenting the ability to
ensure accurate digital data collection and reporting on community and
client level activities, including those that correspond to treatment
plans. The applicant should describe how their program intends to
evaluate its activities to include successes, challenges, outputs, and
outcomes. Some examples of activities include training of staff on
observation and signs to look for in clients encountering the
detoxification program; safety protocols; organizational protocols and
procedures; safety plans; data collection methods and support systems
for collecting data; partnerships developed and sustained; and recovery
support activities provided for clients.
Part 3: Program Report (Limit--2 Pages)
Section 1: Describe your organization's significant program
activities and accomplishments as a detoxification program over the
past 5 years associated with the goals of this announcement. Please
identify current staffing and key personnel who will be responsible for
the management of the cooperative agreement.
Additionally, the applicant's should describe their ability to
report on collaboration and networking with local partners. Reporting
elements will pertain to activities, processes, barriers, and outcomes
and include any partners who will assist in evaluation efforts if
separate from the primary applicant.
B. Budget Narrative (Limit--5 Pages)
Provide a budget narrative that explains the amounts requested for
each line item of the budget from the SF-424A (Budget Information for
Non-Construction Programs) for the first year of the project. The
applicant can submit with the budget narrative a more detailed
spreadsheet than is provided by the SF-424A (the spreadsheet will not
be considered part of the budget narrative). The budget narrative
should specifically describe how each item will support the achievement
of proposed objectives. Be very careful about showing how each item in
the ``Other'' category is justified. Do NOT use the budget narrative to
expand the project narrative.
3. Submission Dates and Times
Applications must be submitted through Grants.gov by 11:59 p.m.
Eastern Time on the Application Deadline Date. Any application received
after the application deadline will not be accepted for review.
Grants.gov will notify the applicant via email if the application is
rejected.
If technical challenges arise and assistance is required with the
application process, contact Grants.gov Customer Support (see contact
information at https://www.Grants.gov). If problems persist, contact
Mr. Paul Gettys, Deputy Director, DGM, by email at [email protected]. Please
be sure to contact Mr. Gettys at least 10 days prior to the application
deadline. Please do not contact the DGM until you have received a
Grants.gov tracking number. In the event you are not able to obtain a
tracking number, call the DGM as soon as possible.
The IHS will not acknowledge receipt of applications.
4. Intergovernmental Review
Executive Order 12372 requiring intergovernmental review is not
applicable to this program.
5. Funding Restrictions
Pre-award costs are allowable up to 90 days before the
start date of the award provided the costs are otherwise allowable if
awarded. Pre-award costs are incurred at the risk of the applicant.
The available funds are inclusive of direct and indirect
costs.
Only one cooperative agreement under this program may be
awarded per applicant.
6. Electronic Submission Requirements
All applications must be submitted via Grants.gov. Please use the
https://www.Grants.gov website to submit an application. Find the
application by
[[Page 12960]]
selecting the ``Search Grants'' link on the homepage. Follow the
instructions for submitting an application under the Package tab. No
other method of application submission is acceptable.
If you cannot submit an application through Grants.gov, you must
request a waiver prior to the application due date. You must submit
your waiver request by email to [email protected], with a copy to Mr. Paul
Gettys, Deputy Director, DGM, at [email protected]. Your waiver
request must include clear justification for the need to deviate from
the required application submission process. The IHS will not accept
any applications submitted through any means outside of Grants.gov
without an approved waiver.
If the DGM approves your waiver request, you will receive a
confirmation of approval email containing submission instructions. You
must include a copy of the written approval with the application
submitted to the DGM. Late applications or application that do not
include a copy of the signed waiver from the Deputy Director of the DGM
will not be reviewed. The Grants Management Officer of the DGM will
notify the applicant via email of this decision. Applications submitted
under waiver must be received by the DGM no later than 5:00 p.m.
Eastern Time on the Application Deadline Date. Late applications will
not be accepted for processing. Applicants that do not register for
both the System for Award Management (SAM) and Grants.gov and/or fail
to request timely assistance with technical issues will not be
considered for a waiver to submit an application via alternative
method.
Please be aware of the following:
Please search for the application package in https://www.Grants.gov by entering the Assistance Listing (CFDA) number or the
Funding Opportunity Number. Both numbers are located in the header of
this announcement.
If you experience technical challenges while submitting
your application, please contact Grants.gov Customer Support (see
contact information at https://www.Grants.gov).
Upon contacting Grants.gov, obtain a tracking number as
proof of contact. The tracking number is helpful if there are technical
issues that cannot be resolved and a waiver from the agency must be
obtained.
Applicants are strongly encouraged not to wait until the
deadline date to begin the application process through Grants.gov as
the registration process for SAM and Grants.gov could take up to 20
working days.
Please follow the instructions on Grants.gov to include
additional documentation that may be requested by this funding
announcement.
Applicants must comply with any page limits described in
this funding announcement.
After submitting the application, you will receive an
automatic acknowledgment from Grants.gov that contains a Grants.gov
tracking number. The IHS will not notify you that the application has
been received.
System for Award Management (SAM)
Organizations that are not registered with SAM must access the SAM
online registration through the SAM home page at https://sam.gov.
Organizations based in the U.S. will also need to provide an Employer
Identification Number from the Internal Revenue Service that may take
an additional 2-5 weeks to become active. Please see SAM.gov for
details on the registration process and timeline. Registration with the
SAM is free of charge but can take several weeks to process. Applicants
may register online at https://sam.gov.
Unique Entity Identifier
Your SAM.gov registration now includes a Unique Entity Identifier
(UEI), generated by SAM.gov, which replaces the DUNS number obtained
from Dun and Bradstreet. SAM.gov registration no longer requires a DUNS
number.
Check your organization's SAM.gov registration as soon as you
decide to apply for this program. If your SAM.gov registration is
expired, you will not be able to submit an application. It can take
several weeks to renew it or resolve any issues with your registration,
so do not wait.
Check your Grants.gov registration. Registration and role
assignments in Grants.gov are self-serve functions. One user for your
organization will have the authority to approve role assignments, and
these must be approved for active users in order to ensure someone in
your organization has the necessary access to submit an application.
The Federal Funding Accountability and Transparency Act of 2006, as
amended (``Transparency Act''), requires all HHS awardees to report
information on sub-awards. Accordingly, all IHS awardees must notify
potential first-tier sub-awardees that no entity may receive a first-
tier sub-award unless the entity has provided its UEI number to the
prime awardee organization. This requirement ensures the use of a
universal identifier to enhance the quality of information available to
the public pursuant to the Transparency Act.
Additional information on implementing the Transparency Act,
including the specific requirements for SAM, are available on the DGM
Grants Management, Policy Topics web page at https://www.ihs.gov/dgm/policytopics/.
V. Application Review Information
Possible points assigned to each section are noted in parentheses.
The project narrative and budget narrative should include only the
first year of activities. The project narrative should be written in a
manner that is clear to outside reviewers unfamiliar with prior related
activities of the applicant. It should be well organized, succinct, and
contain all information necessary for reviewers to fully understand the
project. Attachments requested in the criteria do not count toward the
page limit for the narratives. Points will be assigned to each
evaluation criteria adding up to a total of 100 possible points. Points
are assigned as follows:
1. Evaluation Criteria
The purpose of this funding opportunity is to support programs that
provide detoxification for alcohol use disorders and when appropriate,
other substance use disorders to address its impact in AI/AN
populations and reduce the mortality associated with alcohol and other
substance use. The applicant must describe fully and clearly the
following areas.
A. Part 1: Program Information (40 Points)
1. The impact of alcohol use disorders, alcohol-related deaths,
alcohol-related morbidity, and other social and health issues
attributed to alcohol and other substances in the community they serve.
2. The status of the social detoxification program, who operates
it, the number of employees, how long it has been in operation, and
what programs or services are being provided.
3. Demonstrate the need for funding and how the funding will
complement, enhance, increase, and/or expand the services currently
provided.
4. The applicant's service population, clientele served, average
daily census, and ratio of individuals served who are enrolled members
of federally recognized Tribes to those who are not.
5. The applicant's readiness and capacity to provide services on
day one of the award.
6. The applicant's staffing level, experience and education of
staff, and key personnel who will manage the project.
[[Page 12961]]
B. Part 2: Program Planning and Evaluation (40 Points)
Section 1: Program Planning.
1. The applicant's description of the social detoxification program
that includes the three critical components of evaluation,
stabilization, and fostering patient readiness for and entry into
treatment.
2. The applicant's plans to provide safe housing, including
custodial care in a safe environment.
3. The applicant's process of ensuring employees have passed
background checks and are trained in appropriate alcohol and substance
use disorder identification; withdrawal management; emergency and
crisis intervention training; evidence/culture-based interventions and
best practices; and treatment approaches.
4. The applicant's appropriate monitoring of individuals accessing
services and security measures to ensure safety and prevention of self-
harm and harm to others.
5. Community partnerships and referral networks for health and
behavioral health treatment services, including when medical
intervention is required for stabilization.
6. The applicant's ability to provide transportation to and from
emergency departments.
7. Communication strategies with the client's support system that
fosters the client's recovery efforts upon consent (i.e., family,
social support groups, peer recovery specialists, and traditional
healing services).
8. The applicant's ability to provide activities for daily living
including physical and mental exercises, showers, meals, cultural
activities, blankets, appropriate clothing, and activities that foster
increased self-esteem, self-awareness, and self-efficacy.
9. The applicant's ability to provide clinical and behavioral
health support for medical issues and medication management,
assessments, screening, referral to higher levels of care, and case
management.
Section 2: Program Evaluation.
10. The organization's plan for gathering client-specific non-
identifiable data.
11. The ability to ensure accurate digital data collection and
reporting on community and client level activities.
12. The ability to report on networking and partnering with local
partners through memorandums of agreements/understanding, letters of
support, council/Tribal resolutions, and coalition involvement.
13. The applicant should describe how their program intends to
evaluate its activities to include successes, challenges, outputs, and
outcomes.
C. Part 3: Program Report (10 Points)
1. The applicant's significant program activities and
accomplishments over the past 5 years associated with the goals of this
funding opportunity.
2. Identifies current staffing and key personnel who will be
responsible for the management of the cooperative agreement.
3. The applicant's ability to report on collaboration and
networking with local partners and submit reporting elements that
pertain to activities, processes, barriers, and outcomes.
4. Include any partners who will assist in evaluation efforts if
separate from the primary applicant.
D. Budget Narrative (10 Points)
1. How clearly the applicant demonstrates each budget item aligns
with its proposal and program approach.
2. The degree to which the applicant budgets for evaluation
activities.
Additional documents can be uploaded as Other Attachments in
Grants.gov. These can include:
Work plan, logic model, and/or timeline for proposed
objectives.
Position descriptions for key staff.
Resumes of key staff that reflect current duties.
Consultant or contractor proposed scope of work and letter
of commitment (if applicable).
Current Indirect Cost Rate Agreement.
Organizational chart.
Map of area identifying project location(s).
Additional documents to support narrative (i.e., data
tables, key news articles, etc.).
2. Review and Selection
Each application will be prescreened for eligibility and
completeness as outlined in the funding announcement. Applications that
meet the eligibility criteria shall be reviewed for merit by the
Objective Review Committee (ORC) based on evaluation criteria.
Incomplete applications and applications that are not responsive to the
administrative thresholds (budget limit, period of performance limit)
will not be referred to the ORC and will not be funded. The program
office will notify the applicant of this determination.
Applicants must address all program requirements and provide all
required documentation.
3. Notifications of Disposition
All applicants will receive an Executive Summary Statement from the
IHS DBH within 30 days of the conclusion of the ORC outlining the
strengths and weaknesses of their application. The summary statement
will be sent to the Authorizing Official identified on the face page
(SF-424) of the application.
A. Award Notices for Funded Applications
The Notice of Award (NoA) is the authorizing document for which
funds are dispersed to the approved entities and reflects the amount of
Federal funds awarded, the purpose of the award, the terms and
conditions of the award, the effective date of the award, and the
budget/project period. Each entity approved for funding must have a
user account in GrantSolutions in order to retrieve the NoA. Please see
the Agency Contacts list in Section VII for the systems contact
information.
B. Approved but Unfunded Applications
Approved applications not funded due to lack of available funds
will be held for 1 year. If funding becomes available during the course
of the year, the application may be reconsidered.
Note: Any correspondence, other than the official NoA executed
by an IHS grants management official announcing to the project
director that an award has been made to their organization, is not
an authorization to implement their program on behalf of the IHS.
VI. Award Administration Information
1. Administrative Requirements
Awards issued under this announcement are subject to, and are
administered in accordance with, the following regulations and
policies:
A. The criteria as outlined in this program announcement.
B. Administrative Regulations for Grants:
Uniform Administrative Requirements, Cost Principles, and
Audit Requirements for HHS Awards currently in effect or implemented
during the period of award, other Department regulations and policies
in effect at the time of award, and applicable statutory provisions. At
the time of publication, this includes 45 CFR part 75, at https://www.govinfo.gov/content/pkg/CFR-2021-title45-vol1/pdf/CFR-2021-title45-vol1-part75.pdf.
Please review all HHS regulatory provisions for
Termination at 45 CFR 75.372, at the time of this publication located
at https://www.govinfo.gov/content/pkg/CFR-2021-title45-vol1/pdf/CFR-2021-title45-vol1-sec75-372.pdf.
C. Grants Policy:
[[Page 12962]]
HHS Grants Policy Statement, Revised January 2007, at
https://www.hhs.gov/sites/default/files/grants/grants/policies-regulations/hhsgps107.pdf.
D. Cost Principles:
Uniform Administrative Requirements for HHS Awards, ``Cost
Principles,'' at 45 CFR part 75, subpart E, at the time of this
publication located at https://www.govinfo.gov/content/pkg/CFR-2021-title45-vol1/pdf/CFR-2021-title45-vol1-part75-subpartE.pdf.
E. Audit Requirements:
Uniform Administrative Requirements for HHS Awards,
``Audit Requirements,'' at 45 CFR part 75, subpart F, at the time of
this publication located at https://www.govinfo.gov/content/pkg/CFR-2021-title45-vol1/pdf/CFR-2021-title45-vol1-part75-subpartF.pdf.
F. As of August 13, 2020, 2 CFR part 200 was updated to include a
prohibition on certain telecommunications and video surveillance
services or equipment. This prohibition is described in 2 CFR 200.216.
This will also be described in the terms and conditions of every IHS
grant and cooperative agreement awarded on or after August 13, 2020.
``If you are successful and receive a Notice of Award, in accepting the
award, you agree that the award and any activities thereunder are
subject to all provisions of 45 CFR part 75, currently in effect or
implemented during the period of the award, other Department
regulations and policies in effect at the time of the award, and
applicable statutory provisions.''
2. Indirect Costs
This section applies to all awardees that request reimbursement of
IDC in their application budget. In accordance with HHS Grants Policy
Statement, Part II-27, the IHS requires applicants to obtain a current
IDC rate agreement and submit it to the DGM prior to the DGM issuing an
award. The rate agreement must be prepared in accordance with the
applicable cost principles and guidance as provided by the cognizant
agency or office. A current rate covers the applicable grant activities
under the current award's budget period. If the current rate agreement
is not on file with the DGM at the time of award, the IDC portion of
the budget will be restricted. The restrictions remain in place until
the current rate agreement is provided to the DGM.
Per 45 CFR 75.414(f) Indirect (F&A) costs,
any non-Federal entity (NFE) [i.e., applicant] that has never
received a negotiated indirect cost rate, . . . may elect to charge
a de minimis rate of 10 percent of modified total direct costs which
may be used indefinitely. As described in Section 75.403, costs must
be consistently charged as either indirect or direct costs, but may
not be double charged or inconsistently charged as both. If chosen,
this methodology once elected must be used consistently for all
Federal awards until such time as the NFE chooses to negotiate for a
rate, which the NFE may apply to do at any time.
Electing to charge a de minimis rate of 10 percent only applies to
applicants that have never received an approved negotiated indirect
cost rate from HHS or another cognizant Federal agency. Applicants
awaiting approval of their indirect cost proposal may request the 10
percent de minimis rate. When the applicant chooses this method, costs
included in the indirect cost pool must not be charged as direct costs
to the grant.
Available funds are inclusive of direct and appropriate indirect
costs. Approved indirect funds are awarded as part of the award amount,
and no additional funds will be provided.
Generally, IDC rates for IHS awardees are negotiated with the
Division of Cost Allocation at https://rates.psc.gov/ or the Department
of the Interior (Interior Business Center) at https://ibc.doi.gov/ICS/tribal. For questions regarding the indirect cost policy, please call
the Grants Management Specialist listed under ``Agency Contacts'' or
write to [email protected].
3. Reporting Requirements
The awardee must submit required reports consistent with the
applicable deadlines. Failure to submit required reports within the
time allowed may result in suspension or termination of an active
grant, withholding of additional awards for the project, or other
enforcement actions such as withholding of payments or converting to
the reimbursement method of payment. Continued failure to submit
required reports may result in the imposition of special award
provisions and/or the non-funding or non-award of other eligible
projects or activities. This requirement applies whether the
delinquency is attributable to the failure of the awardee organization
or the individual responsible for preparation of the reports. Per DGM
policy, all reports must be submitted electronically by attaching them
as a ``Grant Note'' in GrantSolutions. Personnel responsible for
submitting reports will be required to obtain a login and password for
GrantSolutions. Please use the form under the Recipient User section of
https://www.grantsolutions.gov/home/getting-started-request-a-user-account/. Download the Recipient User Account Request Form, fill it out
completely, and submit it as described on the web page and in the form.
The reporting requirements for this program are noted below.
A. Progress Reports
Program progress reports are required semi-annually. The progress
reports are due within 30 days after the reporting period ends
(specific dates will be listed in the NoA Terms and Conditions). These
reports must include a brief comparison of actual accomplishments to
the goals established for the period, a summary of progress to date or,
if applicable, provide sound justification for the lack of progress,
and other pertinent information as required. A final report must be
submitted within 90 days of expiration of the period of performance.
B. Financial Reports
Federal Financial Reports are due 90 days after the end of each
budget period, and a final report is due 120 days after the end of the
period of performance. Awardees are responsible and accountable for
reporting accurate information on all required reports: the Progress
Reports and the Federal Financial Report.
Failure to submit timely reports may result in adverse award
actions blocking access to funds.
C. Data Collection and Reporting
All awardees will be required to collect and report data pertaining
to activities, processes, and outcomes. The IHS DBH will provide
guidance on data collection and reporting for evaluation purposes
within 6 months of award. Programmatic reporting must be submitted
within 30 days after the budget period ends for each project year
(specific dates will be listed in the NoA Terms and Conditions). All
reporting items will be submitted via the Grant Solutions. Technical
assistance for web-based data entry will be timely and readily
available to awardees by assigned IHS DBH staff. Awardees are
responsible and accountable for accurate information being submitted by
required due dates for Data Collection and Reporting.
D. Federal Sub-Award Reporting System (FSRS)
This award may be subject to the Transparency Act sub-award and
executive compensation reporting requirements of 2 CFR part 170.
The Transparency Act requires the OMB to establish a single
searchable database, accessible to the public, with
[[Page 12963]]
information on financial assistance awards made by Federal agencies.
The Transparency Act also includes a requirement for awardees of
Federal grants to report information about first-tier sub-awards and
executive compensation under Federal assistance awards.
The IHS has implemented a Term of Award into all IHS Standard Terms
and Conditions, NoAs, and funding announcements regarding the FSRS
reporting requirement. This IHS Term of Award is applicable to all IHS
grant and cooperative agreements issued on or after October 1, 2010,
with a $25,000 sub-award obligation threshold met for any specific
reporting period.
For the full IHS award term implementing this requirement and
additional award applicability information, visit the DGM Grants
Management website at https://www.ihs.gov/dgm/policytopics/.
E. Non-Discrimination Legal Requirements for Awardees of Federal
Financial Assistance
The awardee must administer the project in compliance with Federal
civil rights laws that prohibit discrimination on the basis of race,
color, national origin, disability, age, and comply with applicable
conscience protections. The awardee must comply with applicable laws
that prohibit discrimination on the basis of sex, which includes
discrimination on the basis of gender identity, sexual orientation, and
pregnancy. Compliance with these laws requires taking reasonable steps
to provide meaningful access to persons with limited English
proficiency and providing programs that are accessible to and usable by
persons with disabilities. The HHS Office for Civil Rights provides
guidance on complying with civil rights laws enforced by HHS. See
https://www.hhs.gov/civil-rights/for-providers/provider-obligations/ and https://www.hhs.gov/civil-rights/for-individuals/nondiscrimination/.
Recipients of FFA must ensure that their programs are
accessible to persons with limited English proficiency. For guidance on
meeting your legal obligation to take reasonable steps to ensure
meaningful access to your programs or activities by limited English
proficiency individuals, see https://www.hhs.gov/civil-rights/for-individuals/special-topics/limited-english-proficiency/fact-sheet-guidance/ and https://www.lep.gov.
For information on your specific legal obligations for
serving qualified individuals with disabilities, including reasonable
modifications and making services accessible to them, see https://www.hhs.gov/civil-rights/for-individuals/disability/.
HHS funded health and education programs must be
administered in an environment free of sexual harassment. See https://www.hhs.gov/civil-rights/for-individuals/sex-discrimination/.
For guidance on administering your program in compliance
with applicable Federal religious nondiscrimination laws and applicable
Federal conscience protection and associated anti-discrimination laws,
see https://www.hhs.gov/conscience/conscience-protections/
and https://www.hhs.gov/conscience/religious-freedom/.
F. Federal Awardee Performance and Integrity Information System
(FAPIIS)
The IHS is required to review and consider any information about
the applicant that is in the FAPIIS at https://www.fapiis.gov/fapiis/#/home before making any award in excess of the simplified acquisition
threshold (currently $250,000) over the period of performance. An
applicant may review and comment on any information about itself that a
Federal awarding agency previously entered. The IHS will consider any
comments by the applicant, in addition to other information in FAPIIS,
in making a judgment about the applicant's integrity, business ethics,
and record of performance under Federal awards when completing the
review of risk posed by applicants, as described in 45 CFR 75.205.
As required by 45 CFR part 75, appendix XII of the Uniform
Guidance, NFEs are required to disclose in FAPIIS any information about
criminal, civil, and administrative proceedings, and/or affirm that
there is no new information to provide. This applies to NFEs that
receive Federal awards (currently active grants, cooperative
agreements, and procurement contracts) greater than $10 million for any
period of time during the period of performance of an award/project.
Mandatory Disclosure Requirements
As required by 2 CFR part 200 of the Uniform Guidance, and the HHS
implementing regulations at 45 CFR part 75, the IHS must require an NFE
or an applicant for a Federal award to disclose, in a timely manner, in
writing to the IHS or pass-through entity all violations of Federal
criminal law involving fraud, bribery, or gratuity violations
potentially affecting the Federal award.
All applicants and awardees must disclose in writing, in a timely
manner, to the IHS and to the HHS Office of Inspector General all
information related to violations of Federal criminal law involving
fraud, bribery, or gratuity violations potentially affecting the
Federal award. 45 CFR 75.113.
Disclosures must be sent in writing to: U.S. Department of Health
and Human Services, Indian Health Service, Division of Grants
Management, ATTN: Marsha Brookins, Director, 5600 Fishers Lane, Mail
Stop: 09E47, Rockville, MD 20857. (Include ``Mandatory Grant
Disclosures'' in subject line). Office: (301) 443-4750. Fax: (301) 594-
0899. Email: [email protected].
AND
U.S. Department of Health and Human Services, Office of Inspector
General, ATTN: Mandatory Grant Disclosures, Intake Coordinator, 330
Independence Avenue SW, Cohen Building, Room 5527, Washington, DC
20201. URL: https://oig.hhs.gov/fraud/report-fraud/. (Include
``Mandatory Grant Disclosures'' in subject line). Fax: (202) 205-0604
(Include ``Mandatory Grant Disclosures'' in subject line) or Email:
[email protected].
Failure to make required disclosures can result in any of the
remedies described in 45 CFR 75.371 Remedies for noncompliance,
including suspension or debarment (see 2 CFR part 180 and 2 CFR part
376).
VII. Agency Contacts
1. Questions on the programmatic issues may be directed to: JB
Kinlacheeny, Public Health Advisor, Indian Health Service, Division of
Behavioral Health, 5600 Fishers Lane, Mail Stop: 0834NB, Rockville, MD
20857. Phone: (301) 443-0104. Email: [email protected].
2. Questions on grants management and fiscal matters may be
directed to: Indian Health Service, Division of Grants Management, 5600
Fishers Lane, Mail Stop: 09E47, Rockville, MD 20857, Email:
[email protected]. For technical assistance with Grants.gov, please contact
the Grants.gov help desk at 800-518-4726, or by email at
[email protected].
VIII. Other Information
The Public Health Service strongly encourages all grant,
cooperative agreement, and contract awardees to provide a smoke-free
workplace and promote the non-use of all tobacco products. In addition,
Public Law 103-227, the Pro-Children Act of 1994, prohibits smoking in
certain facilities
[[Page 12964]]
(or in some cases, any portion of the facility) in which regular or
routine education, library, day care, health care, or early childhood
development services are provided to children. This is consistent with
the HHS mission to protect and advance the physical and mental health
of the American people.
Roselyn Tso,
Director, Indian Health Service.
[FR Doc. 2023-04151 Filed 2-28-23; 8:45 am]
BILLING CODE 4165-16-P